Joshua Brody, MD, discusses how he sees the use of immunotherapy evolving in coming years.
Joshua Brody, MD
Advertisement
Articles by Joshua Brody, MD
Joshua Brody, MD, assistant professor, Icahn School of Medicine, director, Lymphoma Immunotherapy Program, Mount Sinai Hospital, discusses vaccine strategies in follicular lymphoma.
Advertisement
Latest Updated Articles
Vaccine Strategies in Follicular LymphomaNovember 5th 2014
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
ESMO 2026: ADCs and New Combinations Advance Lung Cancer Care
2
ADCs Shine, Mixed Bag for Immunotherapy at ESMO 2026 Presidential Symposium III
3
ESMO 2026: Survival Gains and New Treatment Strategies in GI Cancers
4
Late-Breaking Breast Cancer Data at ESMO 2026 Highlight ADCs and Ribociclib
5